The relationship between p27^kip1 expression and the change of radiosensitivity of esophageal carcinoma cells

References

• Parkin DM, Bray F, Ferlay J, Pisani P. Global Cancer Statistics, 2002. CA Cancer J Clin 2005;55:74–108.
   PubMed Web of Science ®Google Scholar
• Sakakura C, Miyagawa K, Fukuda KI, Nakashima S, Yoshikawa T, Kin S, Frequent silencing of RUNX3 in esophageal squamous cell carcinomas is associated with radioresistance and poor prognosis. Oncogene 2007;26:5927–38.
   PubMed Web of Science ®Google Scholar
• Yokoyama S, Mita S, Okabe A, Abe M, Ogawa M. Prediction of radiosensitivity in human esophageal squamous cell carcinomas with heme oxygenase-1: a clinicopathological and immunohistochemical study. Oncol Rep 2001;8:355–8.
   PubMed Web of Science ®Google Scholar
• Matsuyama A, Inoue H, Shibuta K, Tanaka Y, Barnard GF, Sugimachi K, Hepatoma-derived growth factor is associated with reduced sensitivity to irradiation in esophageal cancer. Cancer Res 2001;61:5714–17.
   PubMed Web of Science ®Google Scholar
• Kim AH, Lebman DA, Dietz CM, Snyder SR, Eley KW, Chung TD. Transforming growth factor-beta is an endogenous radioresistance factor in the esophageal adenocarcinoma cell line OE-33. Int J Oncol 2003;23:1593–9.
   PubMed Web of Science ®Google Scholar
• Che SM, Zhang XZ, Hou L, Song TB. Cyclooxygenase-2 inhibitor NS398 enhances radiosensitivity of radioresistant esophageal cancer cells by inhibiting AKT activation and inducing apoptosis. Cancer Invest 2010;28:679–88.
   PubMed Web of Science ®Google Scholar
• Cooper JS, Guo MD, Herskovic A, Macdonald JS, Martenson JA Jr, Al-Sarraf M, Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial. JAMA 1999;281:1623–7.
   PubMed Web of Science ®Google Scholar
• Okaichi K, Ide-Kanematsu M, Izumi N, Morita N, Okumura Y, Ihara M. Variations in sensitivity to ionizing radiation in relation to p53 mutation point Anticancer Res 2008;28:2687–90.
   PubMed Web of Science ®Google Scholar
• Jen KY, Cheung VG. Identification of novel p53 target genes in ionizing radiation response. Cancer Res 2005;65:7666–73.
   PubMedGoogle Scholar
• Khor LY, Moughan J, Al-Saleem T, Hammond EH, Venkatesan V, Rosenthal SA, Bcl-2 and Bax expression predict prostate cancer outcome in men treated with androgen deprivation and radiotherapy on radiation therapy oncology group protocol 92-02. Clin Cancer Res 2007;13:3585–90.
   PubMed Web of Science ®Google Scholar
• Przemeck SM, Duckworth CA, Pritchard DM. Radiation-induced gastric epithelial apoptosis occurs in the proliferative zone and is regulated by p53, bak, bax, and bcl-2. Am J Physiol Gastrointest Liver Physiol 2007;292:G620–7.
   Web of Science ®Google Scholar
• Chang JT, Chan SH, Lin CY, Lin TY, Wang HM, Liao CT, Differentially expressed genes in radioresistant nasopharyngeal cancer cells: gp96 and GDF15. Mol Cancer Ther 2007;6:2271–9.
   PubMed Web of Science ®Google Scholar
• Beskow C, Skikuniene J, Holgersson A, Nilsson B, Lewensohn R, Kanter L, Radioresistant cervical cancer shows upregulation of the NHEJ proteins DNA-PKcs, Ku70 and Ku86. Br J Cancer 2009;101:816–21.
   PubMed Web of Science ®Google Scholar
• Jing Z, Gong L, Xie CY, Zhang L, Su HF, Deng X, Reverse resistance to radiation in KYSE-150R esophageal carcinoma cell after epidermal growth factor receptor signal pathway inhibition by cetuximab. Radiother Oncol 2009;93:468–73.
   PubMed Web of Science ®Google Scholar
• Pawlik TM, Keyomarsi K. Role of cell cycle in mediating sensitivity to radiotherapy. Int J Radiat Oncol Biol Phys 2004;59:928–42.
   PubMed Web of Science ®Google Scholar
• Shin YK, Park JS, Kim HS, Jun HJ, Kim GE, Suh CO, Radiosensitivity enhancement by celecoxib, a cyclooxygenase (COX)-2 selective inhibitor, via COX-2-dependent cell cycle regulation on human cancer cells expressing differential COX-2 levels. Cancer Res 2005;65:9501–9.
   PubMed Web of Science ®Google Scholar
• Abukhdeir AM, Park BH. P21 and p27: roles in carcinogenesis and drug resistance. Expert Rev Mol Med 2008;10:e19.
   PubMedGoogle Scholar
• Wang P, Ma Q, Luo J, Liu B, Tan F, Zhang Z, Nkx3.1 and p27kip1 cooperate in proliferation inhibition and apoptosis induction in human androgen–independent prostate cancer cells. Cancer Invest 2009;27:369–75.
   PubMed Web of Science ®Google Scholar
• Sakai K, Oka K, Matsumoto K, Nakamura T. p27 Nuclear localization and growth arrest caused by perlecan knockdown in human endothelial cells. Biochem Biophys Res Commun 2010;392:403–8.
   PubMed Web of Science ®Google Scholar
• McDonald ER III, El-Deiry WS. Checkpoint genes in cancer. Ann Med 2001;33:113–22.
   PubMed Web of Science ®Google Scholar
• Zhang WG, Tong Q, Wu QM, Li SB, Wang XH. Effect of p27kip1 gene transfer combined with chemotherapy on gastric carcinoma cells growth. Chin J Gastroenterol 2007;12:613–15.
   Google Scholar
• Zhang WG, Wu QM, Yu JP, Tong Q, Xie GJ, Wang XH, Adenovirus expressing p27kip1 suppresses growth of established esophageal carcinoma xenografts. World J Gastroenterol 2005;11:6582–6.
   PubMed Web of Science ®Google Scholar
• Zhang W, Tong Q, Wu Q, Li S, Wang X, Wang Q. Upregulated p27kip1 can downregulate survivin expression and inhibit telomerase activity in gastric carcinoma cells. Cancer Invest 2009;27:898–900.
   PubMed Web of Science ®Google Scholar